Cargando…
Indication-wide drug pricing: Insights from the pharma market
BACKGROUND: Pharmaceutical spending has been increasing rapidly for years and is higher than ever before. To control the rising costs, countries are implementing regulatory frameworks such as (internal) reference pricing, price cuts or generics substitution. Internal reference pricing establishes a...
Autores principales: | Siegmeier, Florian, Büssgen, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422096/ https://www.ncbi.nlm.nih.gov/pubmed/36038951 http://dx.doi.org/10.1186/s40545-022-00451-x |
Ejemplares similares
-
Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades
por: Büssgen, Melanie, et al.
Publicado: (2023) -
BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011) -
Food as pharma: marketing nutraceuticals to India’s rural poor
por: Street, Alice
Publicado: (2015) -
The impact of patent expiry on drug prices: insights from the Dutch market
por: van der Schans, Simon, et al.
Publicado: (2020) -
Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
por: Büssgen, Melanie, et al.
Publicado: (2022)